SMARCB1(INI-1)缺陷型鼻腔鼻窦癌的细胞病理学特征
本研究回顾2家学术机构6例SMARCB1(INI-1)缺陷型鼻腔鼻窦癌(IDSNC)的细针穿刺(FNA)标本,分析其细胞形态学与免疫表型。多数病例呈非角化型鳞状细胞癌样特征,伴坏死背景,部分见横纹肌样细胞;所有病例表达细胞角蛋白且INI-1核表达缺失。FNA可提示IDSNC诊断,确诊需结合临床病史与免疫组化。
要点
- FNA中见非角化型鳞癌样或横纹肌样形态的高级别鼻腔鼻窦癌,应怀疑IDSNC。
- 所有病例INI-1核表达缺失,细胞角蛋白阳性,神经内分泌标志物及p16异常染色阴性。
- 确诊需结合临床病史并确保有材料进行免疫组化检测。
核心结论
- FNA标本中具有非角化型鳞癌或横纹肌样形态的高级别鼻腔鼻窦癌可提示IDSNC诊断。
- 临床病史与免疫组化材料是确诊IDSNC的关键。
研究设计与样本
- 回顾性分析2家学术机构病理档案中具有可用细胞学材料的IDSNC病例,共6例来自6名患者。
- 所有可用的玻片均被复核并进行详细形态学分析。
主要发现
- FNA标本来源:转移灶4例,局部复发1例,原发灶眶内延伸1例。
- 多数病例细胞丰富,呈非角化型鳞状细胞癌特征:黏附性细胞簇和片状 oval 至多边形细胞,细胞边界不清,背景为坏死碎屑。
- 2例见单个横纹肌样细胞,胞质更丰富。
- 细胞核一般小且一致,染色质细,核仁小,核膜轻度不规则;1例见中度核大小不一和多核。
- 凋亡小体在6例中5例常见,核分裂象在6例中3例易见。
关键数值与推荐
- 免疫组化:所有病例表达细胞角蛋白;5例中4例表达p63;所有病例INI-1核表达缺失。
- 所有病例神经内分泌标志物阴性,p16异常染色阴性。
临床怎么用
- 对高级别鼻腔鼻窦癌FNA标本,若呈非角化型鳞癌或横纹肌样形态,应怀疑IDSNC。
- 确诊需结合临床病史并确保有材料进行免疫组化检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: SMARCB1 (INI-1)-deficient sinonasal carcinoma (IDSNC) is a newly described, poorly differentiated carcinoma. Herein, the authors describe the cytopathologic features of IDSNC in fine-needle aspiration (FNA) samples. METHODS: The pathology archives of 2 academic institutions were searched for cases of IDSNC with available cytologic materials. All available slides were reviewed and a detailed morphological analysis was performed. RESULTS: Six cases were identified from 6 patients. FNA specimens were obtained from metastatic sites (4 cases), a local disease recurrence (1 case), and a primary lesion extending into the orbit (1 case). The majority of cases had cellular specimens with features of nonkeratinizing squamous cell carcinoma composed of cohesive clusters and sheets of oval to polygonal cells with indistinct cell borders present within a background of necrotic debris. Two cases had single rhabdoid cells with more abundant cytoplasm. The nuclei generally were small and uniform with fine chromatin, small nucleoli, and mild nuclear membrane irregularities; moderate anisonucleosis and multinucleation were noted in one case. Apoptotic bodies were common in 5 of 6 cases, and readily identifiable mitoses in 3 of 6 cases. Immunohistochemistry demonstrated that all cases expressed cytokeratins, 4 of 5 cases expressed p63, and all cases demonstrated loss of INI-1 nuclear expression. All cases were negative for neuroendocrine markers and aberrant p16 staining. CONCLUSIONS: A diagnosis of IDSNC can be suspected on FNA specimens from patients with high-grade sinonasal carcinomas that have either a nonkeratinizing squamous cell carcinoma or rhabdoid morphology. Clinical history and the availability of material for immunohistochemistry are key in confirming the diagnosis. Cancer Cytopathol 2018. © 2018 American Cancer Society.
引用
- Allard FD, Bell D, Stelow EB, et al. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma. Cancer Cytopathol. 2018. PMID: 29797680. doi:10.1002/cncy.22020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。